Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

10.4K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FFixR: a machine learning framework for accurate somatic mutation calling from FFPE RNA-seq data in cancer.

Bioinformatics (Oxford, England)·2026
Same author

Aged differentiated cells reverse into native stemness-like state by niche cytokines to sustain lifelong homeostasis and tissue repair.

Nature communications·2026
Same author

PD-1 Blockade-Induced DKK1 Expression by CD8+ T Cells Promotes Blood-Brain Barrier Permeabilization.

Cancer discovery·2026
Same author

Immature monocytic cells within tumors differentiate into immunosuppressive cells in resistant tumors to immunotherapy.

iScience·2025
Same author

Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants.

Cell reports. Medicine·2025
Same author

Single-cell meta-analysis of T cells reveals clonal dynamics of response to checkpoint immunotherapy.

Cell genomics·2025

Related Experiment Video

Updated: Sep 21, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K

Estimating tumor mutational burden from RNA-sequencing without a matched-normal sample.

Rotem Katzir1,2, Noam Rudberg2, Keren Yizhak3

  • 1Center for Bioinformatics and Computational Biology, Department of Computer Science and the University of Maryland Institute of Advanced Computer Studies (UMIACS), University of Maryland, College Park, MD, 20742, USA.

Nature Communications
|June 2, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning tool to detect somatic mutations from RNA sequencing data without normal samples. This method accurately identifies cancer driver genes and mutational signatures, aiding in cancer research.

More Related Videos

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.2K
Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms
05:12

Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms

Published on: February 2, 2024

915

Related Experiment Videos

Last Updated: Sep 21, 2025

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.9K
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.2K
Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms
05:12

Author Spotlight: AQRNA-seq Role in Mapping Small RNAs and Unraveling Protein Translation Mechanisms

Published on: February 2, 2024

915

Area of Science:

  • Genomics
  • Computational Biology
  • Oncology

Background:

  • Somatic mutation detection is crucial for cancer research, aiding in identifying cancer driver genes, mutational signatures, and tumor mutational burden (TMB).
  • Previous tools required both tumor RNA and matched-normal DNA.
  • A need exists for methods analyzing RNA sequencing data without matched-normal samples.

Purpose of the Study:

  • To develop and validate a machine learning approach for detecting somatic mutations from RNA sequencing data without a matched-normal sample.
  • To assess the pipeline's performance in identifying key genomic features in cancer.

Main Methods:

  • A machine learning model was developed to classify mutations as somatic or germline based on RNA sequencing data features.
  • The approach was applied to RNA sequencing data from over 450 melanoma samples.
  • Performance was evaluated based on precision, recall, and the accurate identification of mutational signatures and driver genes.

Main Results:

  • The pipeline achieved high precision and recall in detecting somatic mutations from RNA sequencing data.
  • Mutational signatures and cancer driver genes were accurately identified in melanoma samples.
  • RNA-based tumor mutational burden (TMB) showed significant association with patient survival, comparable to DNA-based TMB.

Conclusions:

  • The developed machine learning pipeline effectively detects somatic mutations from RNA sequencing data, even without matched-normal samples.
  • This method enables robust analysis of existing and novel RNA datasets for cancer research.
  • RNA-based TMB is a viable and significant prognostic marker associated with patient survival.